The Development of Contextual Cognitive Behavioural Approach to PDN

• Research type

  Research Study

• Full title

  The Development of Contextual Cognitive Behavioural Approach to Painful Diabetic Neuropathy

• IRAS ID

  224386

• Contact name

  Lance McCracken

• Sponsor organisation

  Kings College London

• Duration of Study in the UK

  2 years, 4 months, 0 days

• Research summary

  It is increasingly clear that Painful Diabetic Neuropathy (PDN) added on to an already debilitating condition, can further deteriorate the wellbeing, functioning, and outcomes of patients. The main objective of this study is to gather a more in-depth understanding of the experience of pain from the perspective of PDN patients, develop and test an innovative psychological treatment for chronic neuropathic pain in PDN, based upon the Acceptance and Commitment Therapy (ACT). ACT is a new form of Cognitive Behavioural Therapy (CBT) that has not yet been applied to PDN patients.

  The main objectives of this research include:
  
  1) A survey that (a) examines treatment needs, and preferences of PDN patients and (b) assesses the suitability of ACT.

  2) A small feasibility trial to test the new treatment.

  This research aims to produce and preliminarily test, a prototype treatment for PDN. The hypothesis is that ACT will be an appropriate model (based partly on the systematic review) and that the treatment will be feasible and acceptable (based on participants' input and testing in a feasibility trial).

• REC name

  London - Surrey Research Ethics Committee

• REC reference

  17/LO/2047

• Date of REC Opinion

  26 Jan 2018

• REC opinion

  Further Information Favourable Opinion